Part 9/11:

While Asia’s life sciences real estate market remains in its infancy compared to Western markets, emerging demand driven by demographic shifts and rising healthcare needs are attracting increased investments. Globally, the sector saw a record USD 18 billion in transactions last year, with Asia accounting for approximately SGD 850 million—an impressive figure given the region's early-stage market development.

Challenges and Investment Strategies

Despite positive growth, barriers persist. Investments may slow due to uncertainties around venture capital funding and regulatory frameworks, which can pose significant hurdles for developers and investors.

To navigate this landscape, experts suggest four strategic approaches: